Tag: Brain metastasis

A Review on Brain Metastases Prognostic Scoring Systems

The most prevalent intracranial tumours are brain metastases (BMs), and about 25% of all cancer patients are identified with this poor prognostic illness condition at some point throughout their therapy. The primary prevailing treatment options normally include palliative radiotherapy, chemotherapy, targeted medicines, immunotherapy, optimum supportive care, and surgery in...
Read More

Management of Brain Metastases with Preoperative Radiosurgery

Nearly 30 percent to 54 percent of all patients are diagnosed with the most common intracranial tumor brain metastases (BMs) during or after their solid cancer treatment courses. Although the prognosis is extremely poor for BM patients, the estimated median OS is usually less than 7 months. However, nowadays,...
Read More